Andrew S Goldstein

13PUBLICATIONS
77CO-AUTHORS
Molecular targetsMicrofluidics and nanofluidicsCancer cell biologyPredictive and prognostic markersMedical physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 09, 2026
Mechanism-Informed Language Modeling and Oxygenated 3D Screening Identify Berberine-Enzalutamide Synergy in Prostate Cancer Models.

|Oct 07, 2026
Cell jamming transition is regulated by mitochondrial pyruvate transport and endocytosis.

|Mar 02, 2026
Polyamine Metabolism as a Metabolic Vulnerability in Prostate Cancer Treated with Supraphysiological Androgens.

Mohammadreza Alizadeh-Ghodsi, Andrew S Goldstein

|Jan 27, 2026
OGDHL Promotes Prostate Cancer Progression and Regulates Neuroendocrine Marker Expression and Nucleotide Abundance.

Matthew J Bernard, Andrea Gallardo, Angel Ruiz

|Sep 08, 2025
Defining aging-associated factors that increase susceptibility to prostate cancer.

Shile Zhang, Ernie Lee, Sachi Bopardikar

|Jun 12, 2025
OGDHL regulates tumor growth, neuroendocrine marker expression, and nucleotide abundance in prostate cancer.

Matthew J Bernard, Angel Ruiz, Johnny A Diaz

Pageof 3

Frequent Collaborators

6 joint publications

Paul C Boutros

5 joint publications

Heather R Christofk

4 joint publications

Matthew J Bernard

3 joint publications

Shuang G Zhao